Inactivation of ERK1/2-CREB Pathway Is Implicated in MK801-induced Cognitive Impairment

Abstract

Objective

Schizophrenia (SZ) is associated with cognitive impairment, and it is known that the activity of cAMP response element binding protein (CREB) decreases in the brain of SZ patients. The previous study conducted by the investigators revealed that the upregulation of CREB improves the MK801-related SZ cognitive deficit. The present study further investigates the mechanism on how CREB deficiency is associated with SZ-related cognitive impairment.

Methods

MK-801 was used to induce SZ in rats. Western blotting and immunofluorescence were performed to investigate CREB and the CREB-related pathway implicated in MK801 rats. The long-term potentiation and behavioral tests were performed to assess the synaptic plasticity and cognitive impairment, respectively.

Results

The phosphorylation of CREB at Ser133 decreased in the hippocampus of SZ rats. Interestingly, among the upstream kinases of CREB, merely ERK1/2 was downregulated, while CaMKII and PKA remained unchanged in the brain of MK801-related SZ rats. The inhibition of ERK1/2 by PD98059 reduced the phosphorylation of CREB-Ser133, and induced synaptic dysfunction in primary hippocampal neurons. Conversely, the activation of CREB attenuated the ERK1/2 inhibitor-induced synaptic and cognitive impairment.

Conclusion

These present findings partially suggest that the deficiency of the ERK1/2-CREB pathway is involved in MK801-related SZ cognitive impairment. The activation of the ERK1/2-CREB pathway may be therapeutically useful for treating SZ cognitive deficits.

Keywords

schizophrenia / cognitive impairments / cAMP response element binding protein / ERK1/2 / MK801

References

[1] KahnRS, SommerIE, MurrayRM, et al.. Schizophrenia. Nat Rev Dis Primers, 2015, 1: 15067

[2] WinshipIR, DursunSM, BakerGB, et al.. An Overview of Animal Models Related to Schizophrenia. Can J Psychiatry, 2019, 64(1): 5-17

[3] McCutcheonRA, ReisM T, HowesOD. Schizophrenia—An Overview. JAMA Psychiatry, 2020, 77(2): 201-210

[4] OwenMJ, SawaA, MortensenPB. Schizophrenia. Lancet, 2016, 388(10039): 86-97

[5] BuckB, GagenEC, LutherL, et al.. Dynamic relationships between emotional distress, persecutory ideation, and metacognition in schizophrenia. J Clin Psychol, 2020, 76(4): 716-724

[6] StepnickiP, KondejM, KaczorAA. Current Concepts and Treatments of Schizophrenia. Molecules, 2018, 23(8): 2087

[7] Garcia AlvarezL, GomarJJ, Garcia-PortillaMP, et al.. Cannabis use and cognitive impairment in schizophrenia and first-episode psychosis. Adicciones, 2019, 31(2): 89-94

[8] MaricNP, JovicicMJ, MihaljevicM, et al.. Improving Current Treatments for Schizophrenia. Drug Dev Res, 2016, 77(7): 357-367

[9] SharmaVK, SinghTG. CREB: A Multifaceted Target for Alzheimer's Disease. Curr Alzheimer Res, 2020, 17(14): 1280-1293

[10] EinochR, WeinrebO, MandiukN, et al.. The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI-antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol, 2017, 27(5): 470-483

[11] XiaoX, ZhangC, Grigoroiu-SerbanescuM, et al.. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders. Mol Psychiatry, 2018, 23(9): 1957-1967

[12] HeretaM, KaminskaK, RogozZ. Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats. Pharmacol Rep, 2019, 71(5): 768-773

[13] KraeuterAK, MashavaveT, SuvarnaA, et al.. Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice. Psychopharmacology (Berl), 2020, 237(5): 1397-1405

[14] GuoC, LiuY, FangMS, et al.. omega-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia. Neurotherapeutics, 2020, 17(3): 1271-1286

[15] FangMS, LiX, QianH, et al.. Omega-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway. J Huazhong Univ Sci Technolog Med Sci, 2017, 37(4): 491-495

[16] ShinE, KashiwagiY, KuriuT, et al.. Doublecortinlike kinase enhances dendritic remodelling and negatively regulates synapse maturation. Nat Commun, 2013, 4: 1440

[17] YinY, GaoD, WangY, et al.. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling. Proc Natl Acad Sci USA, 2016, 113(26): E3773-81

[18] TrostW, FruhholzS. The hippocampus is an integral part of the temporal limbic system during emotional processing: Comment on “The quartet theory of human emotions: An integrative and neurofunctional model” by Koelsch S et al. Phys Life Rev, 2015, 13: 87-88

[19] BartschT, WulffP. The hippocampus in aging and disease: From plasticity to vulnerability. Neuroscience, 2015, 309: 1-16

[20] CooperC, MoonHY, van PraagH. On the Run for Hippocampal Plasticity. Cold Spring Harb Perspect Med, 2018, 8(4): a029736

[21] PennAC, ZhangCL, GeorgesF, et al.. Hippocampal LTP and contextual learning require surface diffusion of AMPA receptors. Nature, 2017, 549(7672): 384-388

[22] LeGatesTA, KvartaMD, TooleyJR, et al.. Reward behaviour is regulated by the strength of hippocampus-nucleus accumbens synapses. Nature, 2018, 564(7735): 258-262

[23] NicollRA. A Brief History of Long-Term Potentiation. Neuron, 2017, 93(2): 281-290

[24] FirthJ, StubbsB, RosenbaumS, et al.. Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull, 2017, 43(3): 546-556

[25] Mihaljevic-PelesA, Bajs JanovicM, SagudM, et al.. Cognitive deficit in schizophrenia: an overview. Psychiatr Danub, 2019, 31(Suppl2): 139-142

[26] AltarCA, VawterMP, GinsbergSD. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology, 2009, 34(1): 18-54

[27] LeeYS, SilvaAJ. The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci, 2009, 10(2): 126-40

[28] BarcoA, PittengerC, KandelER. CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects. Expert Opin Ther Targets, 2003, 7(1): 101-114

[29] BourtchuladzeR, FrenguelliB, BlendyJ, et al.. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell, 1994, 79(1): 59-68

[30] WonJ, SilvaAJ. Molecular and cellular mechanisms of memory allocation in neuronetworks. Neurobiol Learn Mem, 2008, 89(3): 285-292

[31] AmidfarM, de OliveiraJ, KucharskaE, et al.. The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease. Life Sci, 2020, 257: 118020

[32] MayrB, MontminyM. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol, 2001, 2(8): 599-609

[33] ShengM, ThompsonMA, GreenbergME. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science, 1991, 252(5011): 1427-1430

[34] XingJ, KornhauserJM, XiaZ, et al.. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol, 1998, 18(4): 1946-1955